Suppr超能文献

哮喘与慢性阻塞性肺疾病的细胞和分子机制

Cellular and molecular mechanisms of asthma and COPD.

作者信息

Barnes Peter J

机构信息

National Heart and Lung Institute, Imperial College, London, U.K.

出版信息

Clin Sci (Lond). 2017 Jul 1;131(13):1541-1558. doi: 10.1042/CS20160487.

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) both cause airway obstruction and are associated with chronic inflammation of the airways. However, the nature and sites of the inflammation differ between these diseases, resulting in different pathology, clinical manifestations and response to therapy. In this review, the inflammatory and cellular mechanisms of asthma and COPD are compared and the differences in inflammatory cells and profile of inflammatory mediators are highlighted. These differences account for the differences in clinical manifestations of asthma and COPD and their response to therapy. Although asthma and COPD are usually distinct, there are some patients who show an overlap of features, which may be explained by the coincidence of two common diseases or distinct phenotypes of each disease. It is important to better understand the underlying cellular and molecular mechanisms of asthma and COPD in order to develop new treatments in areas of unmet need, such as severe asthma, curative therapy for asthma and effective anti-inflammatory treatments for COPD.

摘要

哮喘和慢性阻塞性肺疾病(COPD)都会导致气道阻塞,并与气道慢性炎症相关。然而,这些疾病之间炎症的性质和部位有所不同,导致病理、临床表现及对治疗的反应各异。在本综述中,对哮喘和COPD的炎症及细胞机制进行了比较,并突出了炎症细胞和炎症介质谱的差异。这些差异解释了哮喘和COPD临床表现及其对治疗反应的不同。尽管哮喘和COPD通常是有区别的,但有些患者表现出特征重叠,这可能是由于两种常见疾病的巧合或每种疾病的不同表型所致。更好地了解哮喘和COPD潜在的细胞和分子机制,对于在未满足需求的领域开发新的治疗方法很重要,如重度哮喘、哮喘的治愈性疗法以及COPD的有效抗炎治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验